Loose Screws Mental Health News

Anti-smoking pill drug Chantix has been linked to mental illness, according to Attorney Daily.

Chantix’s safety is currently under fire, as similar stories of patients with suicidal thoughts, depression and aggressive behavior surface. The FDA received reports of 37 suicides and 491 cases in which people had suicidal thoughts. The FDA also said it “appears increasingly likely that there is an association between Chantix and serious neuropsychiatric symptoms.” An estimated 5 million people use the drug.

How scary is it that people are having mental health issues related to non-mental health drugs?

Steven Kazmierczak, the shooter at NIU, wrote about his problems with mental illness in his graduate school applications. He said he hoped he could be an encouragement to others. I find this interesting that he wrote about his struggle with mental illness considering that at the time, there appeared to be no official record of him having a mental illness.

Last but not least, here’s news that would make the TAC proud: Dr. Jeffrey Swanson, a medical sociologist from Duke says that people suffering from mental illness are three times as likely to commit violent acts than "normal" people. To his credit, he adds:

“It’s also correct to say that the large majority of people with mental illness don’t commit violent behavior,” he said.

Further down in the article, WRAL Health Team Physician Dr. Allen Mask answers where all the violent acts come from if not from the mentally ill.

“Dr. Swanson says that if we could eliminate drug and alcohol addiction, we would see violent crime go down by a third. We also have the issues of people being abused as children and children growing up in violent, impoverished environments. They’re at greater risk of becoming violent adults,” Mask said.

Maybe I’m wrong here but isn’t substance abuse classified as a mental illness?

Loose Screws Mental Health News

"Can an antipsychotic drug from the 1950s be paired with a 1980s antibiotic to shrink 21st-century tumors?"

That's the first line from the NYT's recent article on biotech companies mixing two unrelated generic drugs to treat medical problems. Alexis Borisy, the executive of CombinatoRx, is spearheading the movement to mix and match two different generic drugs in the hopes that the combo will cure or effectively treat a disease that may be unrelated to the drugs' initial purposes.

"Orexigen, in creating its obesity drug Contrave, took a treatment used for drug and alcohol addiction and combined it with an antidepressant sometimes used to help people quit smoking." (My guess is that the antid was Zyban.)

It's a nice concept, but I'd hate to see risk of side effects doubled. One med can be a doozy; coupled with another could turn out to be problematic.


More from the NYT: Pharmaceutical companies pay psychiatrists (to push their products) more than doctors in any other specialty.

"For instance, the more psychiatrists have earned from drug makers, the more they have prescribed a new class of powerful medicines known as atypical antipsychotics to children, for whom the drugs are especially risky and mostly unapproved."

The bipolar child paradigm.

Vermont officials disclosed Tuesday that drug company payments to psychiatrists in the state more than doubled last year, to an average of $45,692 each from $20,835 in 2005. Antipsychotic medicines are among the largest expenses for the state’s Medicaid program.

Over all last year, drug makers spent $2.25 million on marketing payments, fees and travel expenses to Vermont doctors, hospitals and universities, a 2.3 percent increase over the prior year, the state said.

The number most likely represents a small fraction of drug makers’ total marketing expenditures to doctors since it does not include the costs of free drug samples or the salaries of sales representatives and their staff members. According to their income statements, drug makers generally spend twice as much to market drugs as they do to research them.

Doesn't the last sentence make you feel all warm and fuzzy inside? It's great to know that getting people to use drugs are more important to these companies than making sure these drugs are safe to use. Yeah, yeah, I know, it's a company and companies are only out to make profits. Whatever kind of optimist is in me wants to believe that maybe there's one doctor out there who is more motivated by helping others than by pharma-backing money. But I'm only a slight optimist.